Procurement
Expert Panel
Create New Account
Login
logo
Report store
Insights
Survey
Consulting
Book discovery call
logo

India Blood Gas and Cardiac Biomarker POC Analyzer Market Outlook to FY’2025

By Product (Device and Reagent), By Device Type (Medium to High Workload and Single Test Analyzer Device), By Region (Tier 1, Tier 2 and Tier 3) and By End User (Hospital, Clinics and Small Health Setup and Diagnostic Labs)

Region:Asia

Author(s):Abhishek Dugar

Product Code:KR930

Download Sample Report
Published On

December 2019

Total pages

122

About the Report

The report titled publication "India Blood Gas and Cardiac Biomarker POC Analyzer Market Outlook to FY'2025-By Product (Device and Reagent), By Device Type (Medium to High Workload and Single Test Analyzer Device), By Region (Tier 1, Tier 2 and Tier 3) and By End User (Hospital, Clinics and Small Health Setup and Diagnostic Labs)"  provides a comprehensive analysis of the blood gas and cardiac biomarker POC analyzer market in India. The report also covers the overview and genesis of the industries, overall market size in terms of revenue, segmentation on the basis of product category, device type, sales by region and end user, trends and developments, issues and challenges, government regulations, value chain analysis, SWOT analysis, competitive scenario and company profiles of major players in both, blood gas and cardiac POC analyser industry. The report concludes with future market projection and analyst recommendations highlighting the major opportunities and cautions for new and existing players in the market.
India Blood Gas and Cardiac Biomarker POC Analyzer Market Revenue

India Blood Gas and Cardiac Biomarker POC Analyzer Market Overview and Size

India blood gas and cardiac biomarker POC analyzer market grew at a double digit growth rate over the review period FY’2014-FY’2019. The market growth was supported by increase in public healthcare expenditure, growth in healthcare infrastructure in the country and rise in elderly population. The markets were observed to be in growth stage and will continue to remain so in the coming years. The demand for low cost devices and cheap cost per test alongwith change in decision making authority from doctors to hospital administration has significantly affected the growth in the market and has changed the procurement landscape in the industry.
 

India Blood Gas and Cardiac Biomarker POC Analyzer Market Segmentation

By Product: Reagent dominated the market as they have higher replacement rate while devices are kept on reagent rental leading to lower sales of devices.
 
By Type of Device: Higher workload devices dominated the blood gas POC market as blood gas analysis is a acute care portfolio which observes higher number of tests being conduced while cardiac biomarker POC industry is observed to be dominated by semi automated small portable systems as low cost devices are preferred in the market owing to limited number of tests being conducted.
 
By Region: The blood gas POC industry witnessed Tier-2 region generating the maximum revenue followed by Tier-1 and Tier-3 as end users in Tier-2 cannot comply for placing device on reagent rental due to limited workload. Therefore, they end up buying the device which results in higher revenue realization for the industry from this region. On the other hand, the cardiac biomarker POC industry witnessed Tier-1 generating the highest revenue due to the presence of better healthcare infrastructure and maximum procedures happening in this region, leading to higher workload demand from Tier-1 followed by Tier-2 and Tier-3.
 
By End User: Hospitals were found to be the biggest end users which generated the maximum revenue for blood gas and cardiac biomarker POC industry during the review period as both the markets are based on acute care for which maximum patients undergo diagnosis and prognosis in hospitals. Clinics and small health setups along with diagnostic labs occupied the remaining share of the revenue pie due to limited workload for these end users.
 
By Type of Biomarker: Troponin dominated the cardiac biomarker POC industry as it is a true diagnostic marker for determining mycordial damage. CKMB occupied the second biggest revenue market share as it is tested frequently for determing the prognosis of cardiac disease followed by NTproBNP which is also tested regularly to comprehend heart valve disease which has high concentration of patients in the subcontinent. Markers such as D-dimer, CRP and Procalcitronin occupied remaining share of the industry as these are used for understanding inflammation in coronary arteries and have low test volume.
 

Competitive Landscape

 
India Blood gas POC analyzer industry is highly concentrated with major revenue of the industry being generated by international players such as Radiometer, Siemens Healthcare, Instrumentation Laboratory, Abbott Healthcare, Roche Diagnostics and OPTI Medical System. Other players in the industry include companies such as Guangzhou Wondfo, Sensa Core, Eden and Aspen which occupy low share in the market. The blood gas POC industry has witnessed higher device sales coming from handheld analyzers by Abbott and Siemens while higher workload systems by Radiometer and Instrumentation laboratory have more number of installations on reagent rental basis in the country. The cardiac biomarker POC analyzer industry is concentrated in the hands of players like Biomerieux, Quidel, Abbott, Wondfo and Radiometer. Other players in the industry such as Roche, Diasys, Boditech, Siemens and Agappe market low cost semi automated devices and occupy the remaining share in the market. In both the markets, players compete on basis of price, technology, branding, placement of devices and product portfolio. 
 
India Blood Gas and Cardiac Biomarker POC Analyzer Market Future Outlook
 
The blood gas and cardiac biomarker POC analyzer industry is expected to witness a double digit growth rate in the forecast period FY’2019-FY’2025. Rapid growth in healthcare expenditure, increase in number of hospitals, shift towards automated systems for managing higher workload, adoption of high sensitivity prognostic and diagnostic markers and increasing penetration of healthcare facilities in Tier-2 and Tier-3 region are expected to bring positive growth in the market in the coming years.
 

Blood Gas POC Analyzer Market:

  • By Type of Product (Reagent and Device)
  • By Type of Device (Medium to High Workload Device and Single Test Analyzer Device)
  • By Region (Tier-1, Tier-2 and Tier-3)
  • By End User (Hospital, Clinics and Small Health Setup and Diagnostic Lab)

Cardiac Biomarker POC Analyzer Market:

  • By Type of Product (Reagent and Device)
  • By Type of Device (Semi-Automated Small Portable System and Fully-Automated High End System)
  • By Type of Cardiac Biomarker (Troponin, CKMB, NTproBNP, D-Dimer, CRP, Procalcitonin and Others)
  • By Region (Tier-1, Tier-2 and Tier-3)
  • By End User (Hospital, Clinics and Small Health Setup and Diagnostic Lab)

Key Topics Covered in the Report

  • India Blood Gas and Cardiac Biomarker POC Analyzer Market Value Chain Analysis
  • India Blood Gas and Cardiac Biomarker POC Analyzer Market Overview
  • India Blood Gas and Cardiac Biomarker POC Analyzer Market Size
  • India Blood Gas and Cardiac Biomarker POC Analyzer Market Ecosystem
  • India Blood Gas and Cardiac Biomarker POC Analyzer Market Segmentation
  • Government Role and Regulation in India Blood Gas and Cardiac Biomarker POC Analyzer Market
  • Trends and Developments in Blood Gas and Cardiac Biomarker POC Analyzer Market
  • Issues and Challenges in India Blood Gas and Cardiac Biomarker POC Analyzer Market
  • Competitive Landscape in India Blood Gas and Cardiac Biomarker POC Analyzer Market
  • Strength and Weakness of Major Players in India Blood Gas and Cardiac Biomarker POC Analyzer Market
  • End User Perception in India Blood Gas and Cardiac Biomarker POC Analyzer Market
  • SWOT Analysis India Blood Gas and Cardiac Biomarker POC Analyzer Market
  • India Blood Gas and Cardiac Biomarker POC Analyzer Market Future Projections, FY’2019-FY’2025F
  • Analyst Recommendations

Products

Key Target Audience

  • Blood Gas Device Manufacturers
  • Blood Gas Reagent Manufacturers
  • Blood Gas Device Importers
  • Government Agencies
  • Cardiac Biomarker Analyzer Manufacturers
  • Cardiac Biomarker Reagent Manufacturers
  • Cardiac Biomarker Device Importers
  • Blood Gas and Cardiac Biomarker Analyzer Distributors

Time Period Captured in the Report:

  • Historical Period: FY’2014- FY’2019
  • Forecast Period: FY’2020F– FY’2025F

Companies

Companies Covered:

Blood Gas POC Analyzer:

  • Radiometer
  • Siemens Healthcare
  • Instrumentation Laboratory
  • Abbott Healthcare
  • Roche Diagnostics
  • OPTI Medical System
  • Guangzhou Wondfo Biotech

Cardiac Biomarker POC Analyzer:

  • Biomerieux
  • Quidel Diagnostics    
  • Abbott Healthcare
  • Guangzhou Wondfo Biotech
  • Radiometer
  • Roche Diagnostics
  • Diasys Diagnostics
  • Boditec Med Inc
  • Agappe Diagnostics
  • Siemens Healthcare

Table of Contents

1. Executive Summary

2. Research Methodology

2.1. Market Definitions

2.2. Abbreviations

2.3. Market Sizing and Modeling

2.4Consolidated Research Approach

2.5Market Sizing Approach – India Blood Gas and Cardiac Biomarker POC Analyzer Market

2.6Sample Size Inclusion Table

2.7Variables (Dependent and Independent)

2.8Multi Factor Based Sensitivity Model

2.9Regression Matrix

2.10Limitations

2.11Final Conclusion

3. Market Overview and Genesis

4. India Blood Gas and Cardiac Biomarker POC Analyzer Market Ecosystem

5. Value Chain Analysis for India Blood Gas and Cardiac Biomarker POC Analyzer Industry (Inter Entity Relationship and Margin Analysis)

6. India Blood Gas and Cardic Biomarker POC Analyzer Market Size, FY’2014-FY’2019

6.1. India Blood Gas POC Analyzer Market Size, FY’2014-FY’2019

7. India Blood Gas POC Analyzer Market Segmentation

7.1. By Type of Product (Reagent and Device), FY’2019

7.2. By Type of Device (Medium to High Workload and Single Test Analyzer Device), FY’2014 and FY’2019

7.3. By Region (Tier 1, Tier2 and Tier 3), FY’2014 and FY’2019

7.4. By Type of End User (Hospital, Clinics and Small Health Setupand Diagnostic Labs), FY’2014 and FY’2019

8. India Cardiac Biomarker POC Analyzer Market, FY’2014-FY’2019

9. India Cardiac Biomarker POC Analyzer Market Segmentation

9.1. By Type of Product (Reagent and Device), FY’2019

9.2. By Type of Device (Semi Automated Small Portable System and Fully Automated High End System), FY’2014 and FY’2019

9.3. By Type of Cardic Bio-Marker (Troponin, CKMB, NTproBNP, D-Dimer, CRP, Procalcitonin and Others), FY’2019

9.4. By Region (Tier 1, Tier2 and Tier 3), FY’2014 and FY’2019

9.5. By Type of End User (Hospital, Clinics and Small Health Seupand Diagnostic Labs, FY’2014 and FY’2019

10. Competitive Landscape in India Blood Gas POC Analyzer Market

10.1. Competitive Scenario Competition Structure (Stage and Nature), Competition Strategies and Company Positioning

10.2. Cross Comparision of Major Players (Radiometer, Siemens Healthcare, Instrumentation Laboratory, Abbott and Roche Diagnostics) in India Blood Gas POC Analyzer Market

10.3. Market Share of Major Players (Radiometer, Siemens, Instrumentation Laboratory, Abbott, Roche Diagnostics, Opti cca, Wondfo and Others) in India Blood Gas POC Analyzer Market, FY’2019

10.4. Heat Map Analysis

11. Competitive Landscape in India Cardiac Biomarker POC Analyzer Market

11.1. Competitive Scenario Competition Structure (Stage and Nature), Competition Strategies and Company Positioning

11.1. Cross Comparision of Major Players (Biomerieux, Quidel, Abbott, Wondfo, Radiometer, Roche Diagnostics, Diasys, Boditech, Siemens Healthcare, Agappe Diagnostics) in India Cardiac Bio-Marker POC Analyzer

11.2. Market Share of Major Players (Biomerieux, Quidel, Abbott, Wondfo, Radiometer, Roche Diagnostics, Diasys, Boditech, Aggape Diagnostics, Siemens Healthcare and Others) in India Cardiac Biomarker POC Analyzer Market, FY’2019

11.3. Heat Map Analysis

12. Strength and Weakness of Major Players in India Blood Gas and Cardiac Biomarker POC Analyzer Market

13. Government Role and Regulations in India Blood Gas and Cardiac Biomarker POC Analyzer Market

14. Issues and Challenges in India Blood Gas and Cardiac Biomarker POC Analyzer Market

14.1 Competitive Pricing

14.2Regional Presence and Maintenance Cost

14.3Product Issues

14.4 Lack of Awareness

15. Trends and Developments in India Blood Gas and Cardiac Biomarker POC Analyzer Market

15.1New Market Entries

15.2New Additions in Market

15.3 Shift towards Fully Automated System

15.4 Incidences of Stroke Related Cases in India

16. End User Perception in India Blood Gas and Cardiac Biomarker POC Analyzer Market

17. Company Profiles of Major Players in India Blood Gas AND Cardiac Biomarker POC Analyzer Market (Company Overview, Revenue, Expenses, Business Strategy, Recent Developments and Future Plans)

17.1. Radiometer (Danaher/Videojet Technologies)

17.2. Biomerieux India Private Limited

17.3. Siemens Healthcare Private Limited

17.4. Roche Diagnostics India Private Limited

17.5. Abbott Healthcare Private Limited/Alere Medical Private Limited

17.6. Instrumentation Laboratory India Pvt Ltd

17.7. Quidel Diagnostics India Private Limited

17.8. Guangzhou Wondfo Biotech Co., Ltd

17.9. OPTI Medical Systems (Idexx Laboratories)

17.10. Diasys Diagnostics India Private Limited

17.11. Boditech Med Inc (ichroma)

17.12. Agappe Diagnostics Limited

18. SWOT Analysis of India Blood Gas and Cardiac Biomarker POC Analyzer Market

19. India Blood Gas POC Analyzer Market Future Outlook and Projections, FY’2019-FY’2025F

19.1. By Type of Device (Medium to High Workload and Single Test Analyzer), FY’2019 and FY’2025F

19.2. By Region (Tier-1, Tier-2 and Tier-3), FY’2019 and FY’2025F

19.3. By Type of End User (Hospital, Clinics and Small Health Seupand Diagnostic Labs, FY’2019 and FY’2025F

20. India Cardiac Biomarker POC Analyzer Market Future Outlook and Projections, FY’2019-FY’2025F

20.1. By Type of Product (Reagent and Device), FY’2025F

20.2. By Type of Device (Semi Automated Small Portable System and Fully Automated High End System), FY’2019 and FY’2025F

20.3. By Type of Marker (Troponin, CKMB, NTproBNP, D-Dimer, CRP, Procalcitonin and Others),

20.4. By Region (Tier 1, Tier2 and Tier 3), FY’2019 and FY’2025F

20.5. By Type of End User (Hospital, Clinics and Small Health Seupand Diagnostic Labs, FY’2019 and FY’2025F

21. Analyst Recommendations

Disclaimer

Contact Us

Why Buy From Us?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022